Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): evaluation report
01. NICE’s response to comments on the Appraisal Consultation Document (ACD)
02. Consultee comments on the ACD - Lilly UK
03. Consultee comments on the ACD – Pumping Marvellous Foundation
04. Consultee comments on the ACD – Pumping Marvellous Foundation 2
05. Consultee comments on the ACD – Royal College of Nursing
06. Commentator comments on the ACD – AstraZeneca
07. Commentator comments on the ACD – Healthcare Improvement Scotland
08. Public comments on the ACD received through the NICE website
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): evaluation report
20 June 2014 (1.14 Mb 38 sec) |
This page was last updated: 18 June 2014